'Our products are fully compliant': Nestle India responds to FSSAI action over infant products

FSSAI said a sample of the product was found to be sub-standard with respect to its Biotin content during laboratory analysis. The sample was subsequently sent for re-analysis, after which a referral laboratory also found it did not conform to the prescribed Biotin requirement under the 2020 regulations.